Mark D. Tattoli - 31 Dec 2025 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Signature
/s/ Mark D. Tattoli
Issuer symbol
CLB
Transactions as of
31 Dec 2025
Net transactions value
-$229,389
Form type
4
Filing time
05 Jan 2026, 15:18:37 UTC
Previous filing
02 Oct 2025
Next filing
17 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tattoli Mark Damian SVP, Gen Counsel & Secretary 6316 WINDFERN ROAD, HOUSTON /s/ Mark D. Tattoli 05 Jan 2026 0001872069

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Stock Tax liability $229,389 -14,310 -34% $16.03 27,361 31 Dec 2025 Direct
transaction CLB Common Stock Options Exercise $0 +24,952 +149% $0.000000 41,671 31 Dec 2025 Direct
holding CLB Common Stock 20 31 Dec 2025 Custodial account
holding CLB Common Stock 1,695 31 Dec 2025 401 (k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Options Exercise $0 -24,952 -100% $0.000000 0 31 Dec 2025 Common Stock 24,952 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were awarded as restricted performance shares in February 2023, as disclosed in the Reporting Person's Form 4 filing on February 21, 2023. The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025. Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025.